These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2961306)

  • 1. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
    Suzuki F; Okuno Y; Maeda Y; Maeda H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3305-12. PubMed ID: 2961306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
    Oda T; Sato F; Yamamoto H; Akagi M; Maeda H
    Anticancer Res; 1989; 9(2):261-5. PubMed ID: 2526613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
    Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
    Oda T; Sato F; Maeda H
    J Natl Cancer Inst; 1987 Dec; 79(6):1205-11. PubMed ID: 2961908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.
    Suzuki F; Pollard RB; Maeda H
    Cancer Immunol Immunother; 1989; 30(2):97-104. PubMed ID: 2480846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
    Kimoto A; Konno T; Kawaguchi T; Miyauchi Y; Maeda H
    Cancer Res; 1992 Feb; 52(4):1013-7. PubMed ID: 1531320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS.
    Takeshita J; Maeda H; Kanamaru R
    Gan; 1982 Apr; 73(2):278-84. PubMed ID: 6214446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effect of YM881 (SMANCS) on glioma cells in vitro.
    Kuratsu J; Takaki S; Kochi M; Mihara Y; Ushio Y
    Anticancer Res; 1991; 11(6):1957-61. PubMed ID: 1837980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cytotoxic effects of the high- and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro.
    Miyamoto Y; Oda T; Maeda H
    Cancer Res; 1990 Mar; 50(5):1571-5. PubMed ID: 2137371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer.
    Oda T; Maeda H
    Cancer Res; 1987 Jun; 47(12):3206-11. PubMed ID: 2953411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F; Munakata T; Maeda H
    Anticancer Res; 1988; 8(1):97-103. PubMed ID: 2451896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
    Abe S; Otsuki M
    Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):715-26. PubMed ID: 12678722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action mechanisms of zinostatin stimalamer (YM881)].
    Tanaka S; Numasaki Y; Maeda H
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2295-300. PubMed ID: 1834022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.
    Oda T; Yamamoto H; Miki T; Maeda H
    Jpn J Cancer Res; 1989 Apr; 80(4):394-9. PubMed ID: 2526108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M; Konno T; Ohtsuka N; Mizumachi R; Oda T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
    Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the microvascular architecture of colorectal liver metastases following the administration of SMANCS/lipiodol.
    Kuruppu D; Christophi C; Maeda H; O'Brien PE
    J Surg Res; 2002 Mar; 103(1):47-54. PubMed ID: 11855917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of macrophage by polyanions and its conjugated proteins and effect on cell membrane.
    Oda T; Morinaga T; Maeda H
    Proc Soc Exp Biol Med; 1986 Jan; 181(1):9-17. PubMed ID: 2935880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
    Maeda H
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stability of high molecular weight anticancer agent SMANCS and its transfer from oil-phase to water-phase. Comparative study with neocarzinostatin].
    Hirayama S; Sato F; Oda T; Maeda H
    Jpn J Antibiot; 1986 Mar; 39(3):815-22. PubMed ID: 3016359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.